Skip to content
Search

Latest Stories

McKesson UK names Chris Keen as CFO

McKesson UK today announced the appointment of Chris Keen as its Chief Finance Officer (CFO).

In this new role, Keen will oversee the financial operations of all McKesson UK businesses including LloydsPharmacy, AAH Pharmaceuticals and John Bell and Croyden.


He will directly report to CEO Toby Anderson and form part of the company’s Executive Leadership team.

Commenting on his new role, Keen said: “I’m delighted to be joining such a customer-centric organisation. I’m looking forward to being part of the business that is a leading partner in the transformation of healthcare in the UK. There are many challenges facing the sector now, not least from a funding perspective, but I’m hoping my experience can help accelerate the many exciting growth areas”.

Keen has 26 years’ experience within the retail - working in sectors ranging from leisure to healthcare. Most recently, he was the Group CFO for Holland & Barrett, previous to which he worked at Boots.

McKesson UK CEO, Toby Anderson, said: “Chris is an accomplished senior executive, having worked in both the wholesale and retail sectors. His experience and breadth of knowledge will be extremely valuable for our business. I’m confident he will be able to help us successfully navigate our current and future challenges”.

More For You

national prescribing service for pharmacists

Sadik Al-Hassan MP

Sadik-Al-Hassan: National pharmacy prescribing service “entirely possible”

A national prescribing service for pharmacists could in theory be developed in the next two-three years according to Sadik-Al-Hassan MP.

Speaking at an event organised by PharmaTech in parliament on Wednesday, Hassan said community pharmacists had the skillset to prescribe but a national service would be “limited” by what they are currently allowed to do.

Keep ReadingShow less
First daily pill for endometriosis to be available on NHS

Instead of travelling to clinics for injections, endometriosis patients can take a daily tablet at home

Getty Images

New endometriosis pill approved for NHS use, but only few patients will benefit

The National Institute for Health and Care Excellence (NICE) has approved a new pill for the treatment of endometriosis, providing hope for thousands of women affected by the debilitating condition.

The pill, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill approved for use in the UK to treat endometriosis, and it is expected to help about 1,000 patients every year.

Keep ReadingShow less
​RPS urges its members and fellows to vote in favour of Royal College for “a stronger, louder voice”

The Special Resolution Vote will remain open until 5 p.m. on Thursday, 24 March 2025.

Getty Images

Royal College voting begins: A historic moment in the profession’s evolution

Becoming a royal college will ensure pharmacy profession gains the recognition and authority it deserves, says RPS president Professor Claire Anderson.

Starting today (13), members and fellows of the Royal Pharmaceutical Society (RPS) will begin voting on the proposed changes to its Royal Charter, marking the beginning of a historic shift toward becoming the Royal College of Pharmacy.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less